Institute Of Hematology & Blood Diseases Hospital, China
Clinical trials sponsored by Institute Of Hematology & Blood Diseases Hospital, China, explained in plain language.
-
Experimental drug trial for tough anemia cases halted early
Disease control TerminatedThis early-stage study tested a low-dose chemotherapy drug (decitabine) in people with a severe form of anemia that did not improve with standard immune-suppressing treatments. Only 3 patients were enrolled before the study was stopped early. The goal was to see if the drug could…
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 01, 2026 14:21 UTC
-
Gene hunt in leukemia: what IDH mutations mean for patients
Knowledge-focused TerminatedThis study examined stored blood samples from over 1,000 adults with acute myeloid leukemia (AML) to find how often IDH1 and IDH2 gene mutations occur and how they affect patient outcomes. The goal was to learn more about these mutations in Chinese patients, not to test a new tre…
Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Knowledge-focused
Last updated May 01, 2026 14:20 UTC